We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

198 hedge funds and large institutions have $395M invested in Aurinia Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $14.2M

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0.27% more ownership

Funds ownership: 35.19% → 35.46% (+0.27%)

1% less funds holding

Funds holding: 200 → 198 (-2)

19% less capital invested

Capital invested by funds: $487M → $395M (-$92.3M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
198
Holders Change
-2
Holders Change %
-1%
% of All Funds
3.14%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
69
Reduced
49
Closed
23
Calls
$23.6M
Puts
$14.2M
Net Calls
+$9.38M
Net Calls Change
+$7.71M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$23M
2
AC
Armistice Capital
New York
+$13.3M
3
TCM
Tang Capital Management
California
+$5.87M
4
IBT
International Biotechnology Trust
United Kingdom
+$4.57M
5
ECM
ExodusPoint Capital Management
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$8.48M
2
Two Sigma Investments
Two Sigma Investments
New York
-$7.24M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.31M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.27M
5
AC
Antara Capital
New York
-$4.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
126
Public Employees Retirement Association of Colorado
Colorado
$173K – – –
BCV
127
Banque Cantonale Vaudoise
Switzerland
$171K +$51.8K +5,300 +32%
RIA
128
Realta Investment Advisors
Delaware
$171K – – –
SG Americas Securities
129
SG Americas Securities
New York
$165K +$207K +21,182 New
AB
130
Amalgamated Bank
New York
$160K – – –
EDRH
131
Edmond de Rothschild Holding
Switzerland
$155K – – –
BCM
132
Bayesian Capital Management
New York
$151K +$190K +19,400 New
NAS
133
Nicolet Advisory Services
Wisconsin
$148K -$3.91K -400 -2%
OC
134
Oppenheimer & Co
New York
$147K – – –
AQR Capital Management
135
AQR Capital Management
Connecticut
$145K +$72.8K +7,446 +67%
JF
136
Jump Financial
Illinois
$133K -$70.1K -7,168 -30%
RJA
137
Raymond James & Associates
Florida
$132K +$45.5K +4,651 +38%
Osaic Holdings
138
Osaic Holdings
Arizona
$128K +$27.5K +2,813 +21%
Millennium Management
139
Millennium Management
New York
$125K -$6.31K -645 -4%
FRM
140
Fox Run Management
Connecticut
$120K -$376K -38,436 -71%
Toronto Dominion Bank
141
Toronto Dominion Bank
Ontario, Canada
$119K – – –
HM
142
Harvest Management
New York
$117K +$147K +15,000 New
BFM
143
Boothbay Fund Management
New York
$110K +$139K +14,163 New
AIP
144
Almanack Investment Partners
Pennsylvania
$107K – – –
PFGIA
145
Patriot Financial Group Insurance Agency
Massachusetts
$106K -$6.36K -650 -5%
Tudor Investment Corp
146
Tudor Investment Corp
Connecticut
$105K +$132K +13,533 New
AIP
147
Ameritas Investment Partners
Nebraska
$105K +$22.2K +2,271 +20%
BC
148
Bridgefront Capital
Texas
$99.5K +$125K +12,812 New
Pictet Asset Management
149
Pictet Asset Management
Switzerland
$96.5K +$121K +12,415 New
BWM
150
BCS Wealth Management
Tennessee
$95K – – –
4 5
6
7 8

AUPH Hedge Fund Activity: Q3 2023 in Review

198 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q3 2023, worth a combined $395M — down 19% from $487M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AUPH positions and 23 closed out — a net gain of 1 holder — while 69 added to existing stakes and 49 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $23M. The largest seller was Renaissance Technologies, cutting an estimated $8.48M.

  • 198 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q3 2023, down from 200 in Q2 2023.
  • Funds reported $395M of Aurinia Pharmaceuticals stock for Q3 2023, down 19% quarter-over-quarter.
  • 24 funds opened new Aurinia Pharmaceuticals positions in Q3 2023 and 23 closed out, a net change of +1 holder.
  • The largest Aurinia Pharmaceuticals buyer in Q3 2023 was Nuveen, an estimated $23M added.
  • The largest Aurinia Pharmaceuticals seller in Q3 2023 was Renaissance Technologies, an estimated $8.48M sold.

Based on aggregated 13F filings for Q3 2023.